Medicare Enrolled
Dr. Sherif Aboseif, MD
Urology Physician · Oxnard, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aboseif from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aboseif?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aboseif
Dr. Sherif Aboseif is an urology physician in Oxnard, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aboseif performed 7,869 Medicare services across 4,578 unique beneficiaries.
Between the years covered by Open Payments, Dr. Aboseif received a total of $10,863 from 50 pharmaceutical and/or device companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aboseif is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$10,863 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,869
Medicare services
Top 13% in CA for urology physician
4,578
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~414 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,073 | $72 | $146 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
1,042 | $10 | $189 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
731 | $9 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
442 | $129 | $407 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
441 | $109 | $218 |
| Voiding cystourethrogram An imaging procedure that uses X-rays to visualize the bladder and urethra while urine is being passed. |
321 | $98 | $469 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
306 | $339 | $680 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
306 | $29 | $465 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
306 | $40 | $235 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 285 | $135 | $441 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
279 | $99 | $212 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
207 | $181 | $326 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
202 | $217 | $481 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
127 | $117 | $362 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $140 | $436 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
95 | $28 | $83 |
| Complicated insertion of bladder tube | 81 | $132 | $318 |
| Injection, garamycin, gentamicin, up to 80 mg | 69 | $2 | $2 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
67 | $125 | $316 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
63 | $279 | $700 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
48 | $46 | $232 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
41 | $13 | $50 |
| Insertion of temporary bladder tube | 40 | $32 | $138 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
29 | $217 | $528 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
24 | $289 | $576 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
23 | $72 | $193 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
21 | $605 | $1,969 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
20 | $250 | $593 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $336 | $871 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
17 | $493 | $1,306 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
11 | $115 | $339 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
11 | $45 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
17.5% medium
81.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,863
Total received (2018-2024)
Avg $1,552/year across 7 years
Top 19% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
430
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,062 (74.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,488 (22.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$313 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,467
2023
$3,459
2022
$1,465
2021
$1,596
2020
$788
2019
$719
2018
$1,369
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$348
PROCEPT BioRobotics Corporation
$180
Medtronic, Inc.
$138
ABBVIE INC.
$95
Axonics, Inc.
$90
Boston Scientific Corporation
$75
Endo USA, Inc.
$68
ACCORD HEALTHCARE, INC.
$66
Astellas Pharma US Inc
$59
Janssen Biotech, Inc.
$56
Endo Pharmaceuticals Inc.
$42
Myriad Genetic Laboratories, Inc.
$39
Blue Earth Diagnostics Limited
$29
PROGENICS PHARMACEUTICALS, INC.
$28
PFIZER INC.
$28
UROGEN PHARMA, INC.
$27
ConvaTec Inc.
$26
Verity Pharmaceuticals Inc.
$23
Olympus America Inc.
$19
BLUEWIND MEDICAL
$16
C. R. Bard, Inc. & Subsidiaries
$15
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$2,678
Uromedica, Incorporated
$787
Endo Pharmaceuticals Inc.
$753
COLOPLAST CORP
$750
Janssen Biotech, Inc.
$697
Medtronic USA, Inc.
$593
Medtronic, Inc.
$589
Astellas Pharma US Inc
$397
Myriad Genetic Laboratories, Inc.
$333
Rochester Medical Corporation
$261
ABBVIE INC.
$238
PFIZER INC.
$217
Axonics, Inc.
$207
AbbVie Inc.
$205
Progenics Pharmaceuticals, Inc.
$203
PROCEPT BioRobotics Corporation
$202
Boston Scientific Corporation
$196
Myovant Sciences Inc.
$149
Allergan Inc.
$102
ACCORD HEALTHCARE, INC.
$86
Acerus Pharmaceuticals Corporation
$83
C. R. Bard, Inc. & Subsidiaries
$80
Olympus America Inc.
$78
Allergan, Inc.
$76
Endo USA, Inc.
$68
Merck Sharp & Dohme LLC
$61
UroGen Pharma, Inc.
$58
Bayer HealthCare Pharmaceuticals Inc.
$55
180 Medical, Inc.
$51
Blue Earth Diagnostics Limited
$49
Teleflex LLC
$47
Davol Inc.
$45
Merck Sharp & Dohme Corporation
$42
Smith+Nephew, Inc.
$42
AbbVie, Inc.
$41
Sumitomo Pharma America, Inc.
$39
NeoTract Inc.
$34
PROGENICS PHARMACEUTICALS, INC.
$28
UROGEN PHARMA, INC.
$27
Dendreon Pharmaceuticals LLC
$27
ConvaTec Inc.
$26
Accord Healthcare, Inc.
$24
Verity Pharmaceuticals Inc.
$23
Photocure Inc
$21
AstraZeneca Pharmaceuticals LP
$20
DENTSPLY IH Inc.
$16
Tolmar, Inc.
$16
BLUEWIND MEDICAL
$16
MEDIVATION FIELD SOLUTIONS LLC
$13
ABC Home Medical Supply, Inc.
$12
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CURE HYDRO · CURE ULTRA CATHETER · CYSVIEW · ELIGARD · ERLEADA · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · GRAFIX PL · INTERSTIM · INTERSTIM ICON · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Luja Coude · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Nubeqa · ORGOVYX · Olympus Cystoscopes · PELVIC FLOOR REPAIR · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REVI · Rezum Generator · SPEEDICATH · STRAVIX · SpeediCath · TESTOPEL · TOVIAZ · Titan · Trelstar · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
19
Per 100K population
2.3
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aboseif is a clinical cardiology specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aboseif experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Aboseif performed 2,073 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aboseif receive payments from pharmaceutical companies?
Yes. Dr. Aboseif received a total of $10,863 from 50 companies across 430 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aboseif's costs compare to other urology physicians in Oxnard?
Dr. Aboseif's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aboseif) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Oxnard
Browse urology physicians in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Uromedica, Incorporated Payments to Doctors
See all physicians who received payments from Uromedica, Incorporated.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology